Walsh, BT, Seidman, SN, Sysko, R, Gould, M. Placebo response in studies of major depression:
variable, substantial, and growing. JAMA
Dunlop, BW, Thase, ME, Wun, CC, Fayyad, R, Guice-Pabia, CJ, Musgnung, J, et al. A meta-analysis of factors impacting
detection of antidepressant efficacy in clinical trials: the importance
of academic sites.
2012; 37: 2830–6.
Bridge, JA, Birmaher, B, Iyengar, S, Barbe, RP, Brent, DA. Placebo response in randomized controlled trials of
antidepressants for pediatric major depressive disorder.
Am J Psychiatry
2009; 166: 42–9.
Laupacis, A, Sackett, DL, Roberts, RS. An assessment of clinically useful measures of the
consequences of treatment. N Engl J Med
1988; 318: 1728–36.
Furukawa, TA, Akechi, T, Wagenpfeil, S, Leucht, S. Relative indices of treatment effect may be constant
across different definitions of response in schizophrenia
trials. Schizophrenia Res
2011; 126: 212–9.
Sedgwick, P. What is number needed to harm (NNH)?
Kraemer, HC, Morgan, GA, Leech, NL, Gliner, JA, Vake, JJ, Harmon, RJ. Measures of clinical significance.
J Am Acad Child Adolesc Psychiatry
2003; 42: 1524–9.
Kraemer, HC, Kupfer, DJ. Size of treatment effects and their importance to
clinical research and practice. Biol
2006; 59: 990–6.
Rutherford, BR, Pott, E, Tandler, JM, Wall, MM, Roose, SP, Lieberman, JA. Placebo response in antipsychotic clinical trials: a
meta-analysis. JAMA Psychiatry
2014; 71: 1409–21.
Mayberg, HS, Silva, JA, Brannan, SK, Tekell, JL, Mahurin, RK, McGinnis, S, et al. The functional neuroanatomy of the placebo
effect. Am J Psychiatry
2002; 159: 728–37.
Rutherford, BR, Marcus, SM, Wang, P, Sneed, JR, Pelton, G, Devanand, D, et al. A randomized, prospective pilot study of
patient expectancy and antidepressant outcome.
2013; 43: 975–82.
Miller, MD, Frank, E, Reynolds, CF. The art of clinical management in pharmacologic
trials with depressed elderly patients: lessons from the Pittsburgh Study
of Maintenance Therapies in Late-Life Depression.
Am J Geriatr Psychiatry
1999; 7: 228–34.
Rutherford, BR, Sneed, JR, Roose, SP. Does study design affect outcome? The effects of
placebo control and treatment duration in antidepressant
trials. Psychother Psychosom
2009; 78: 172–81.
Posternak, MA, Zimmerman, M. Therapeutic effect of follow-up assessments on
antidepressant and placebo response rates in antidepressant efficacy
trials. Br J Psychiatry
2007; 190: 287–92.
Rutherford, BR, Sneed, JR, Tandler, J, Peterson, BS, Roose, SP. Deconstructing pediatric depression trials: an
analysis of the effects of expectancy and therapeutic
contact. J Am Acad Child Adolesc
2011; 50: 782–95.
Rutherford, BR, Tandler, J, Brown, P, Sneed, JR, Roose, SP. Clinic visits in late-life depression trials:
effects on signal detection and therapeutic outcome.
Am J Geriatr Psychiatry
2014; 22: 1452–61.
Valenstein, M, Eisenberg, D, McCarthy, JF, Austin, KL, Ganoczy, D, Kim, HM. Service implications of providing intensive
monitoring during high risk periods for suicide among VA patients with
depression. Psych Services
2009; 60: 439–44.
Morrato, EH, Libby, AM, Orton, HD, deGruy, FV, Brent, DA, Allen, R, et al. Frequency of provider contact after FDA
advisory on risk of pediatric suicidality with SSRIs.
Am J Psychiatry
Stettin, GD, Yao, J, Verbrugge, RR, Aubert, RE. Frequency of follow-up care for adult and pediatric
patients during initiation of antidepressant therapy.
Am J Manag Care
2006; 12: 453–61.
Mojtabai, R, Olfson, M. National patterns in antidepressant treatment by
psychiatrists and general medical providers: results from the National
Comorbidity Survey Replication. J Clin
2008; 69: 1064–74.
Fournier, JC, DeRubeis, RJ, Hollon, SD, Dimidjian, S, Amsterdam, JD, Shelton, RC, et al. Antidepressant drug effects and depression
severity: a patient-level meta-analysis.
Kirsch, I, Sapirstein, G. Listening to prozac but hearing placebo: a
meta-analysis of antidepressant medication. Prev
1998; 1: .
Rutherford, BR, Mori, S, Sneed, JR, Pimontel, MA, Roose, SP. Contribution of spontaneous improvement to placebo
response in depression: a meta-analytic review. J
Cuijpers, P, van Straten, A, Andersson, G, van Oppen, P. Psychotherapy for depression in adults: a
meta-analysis of comparative outcome studies. J
Consult Clin Psychol
2008; 76: 909–22.
National Institute for Health and Care Excellence.
Depression: The Treatment and Management of Depression in Adults
(Update) (CG 90). NICE,
Garcia, AM. What does ‘work’ mean? Reopening the debate about
clinical significance. Clin Psychol Sci
Huang, AX, Delucchi, K, Dunn, LB, Nelson, JC. A systematic review and meta-analysis of
psychotherapy for late-life depression. Am J
2015; 23: 261–73.
March, J, Silva, S, Petrycki, S, Curry, J, Wells, K, Fairbank, J, et al. Fluoxetine, cognitive–behavioral therapy, and
their combination for adolescents with depression: Treatment for
Adolescents with Depression Study (TADS) randomized controlled
2004; 292: 807–20.